Month: July 2023

With the Supreme Court directing the Medical Counselling Committee to conduct admission rounds for all deemed university seats online, half…

Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the…

The company has said it expects the inoculation to be a major driver of future sales to offset the loss…

Pillar’s targeted assays help oncologists and researchers identify mutations that drive tumour growth. This knowledge is pivotal in making informed…

The recall was first started in May 2023 when 28 incidents and 22 injuries were reported due to device malfunctions.…

The US patent expirations are expected to be nearly $115-125 billion between CY2023 and CY2026. Of this, biosimilars will comprise…

The company used an algorithm called PXDX, shorthand for ”procedure-to-diagnosis,” to identify whether claims met certain requirements, spending an average…

Investors have pinned their hopes on Leqembi as the U.S drugmaker’s money spinner multiple sclerosis and spinal muscular atrophy (SMA)…

Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hematopoietic stem cells (HSCs) to the peripheral…

Becton Dickinson said it expects to begin shipping the devices and recognizing revenue in its fiscal year 2024. It said…